BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu J, Miao L, Sui J, Hao Y, Huang G. Nanoparticle cancer vaccines: Design considerations and recent advances. Asian J Pharm Sci 2020;15:576-90. [PMID: 33193861 DOI: 10.1016/j.ajps.2019.10.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chatzikleanthous D, O'Hagan DT, Adamo R. Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines. Mol Pharm 2021;18:2867-88. [PMID: 34264684 DOI: 10.1021/acs.molpharmaceut.1c00447] [Reference Citation Analysis]
2 Guiren Fritah H, Rovelli R, Lai-lai Chiang C, Kandalaft LE. The current clinical landscape of personalized cancer vaccines. Cancer Treatment Reviews 2022. [DOI: 10.1016/j.ctrv.2022.102383] [Reference Citation Analysis]
3 Li M, Qin M, Song G, Deng H, Wang D, Wang X, Dai W, He B, Zhang H, Zhang Q. A biomimetic antitumor nanovaccine based on biocompatible calcium pyrophosphate and tumor cell membrane antigens. Asian J Pharm Sci 2021;16:97-109. [PMID: 33613733 DOI: 10.1016/j.ajps.2020.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Shi P, Qin J, Luo S, Hao P, Li N, Zan X. Effect of the stiffness of one-layer protein-based microcapsules on dendritic cell uptake and endocytic mechanism. Biomater Sci 2021;10:178-88. [PMID: 34813636 DOI: 10.1039/d1bm01448j] [Reference Citation Analysis]
5 Thangam R, Patel KD, Kang H, Paulmurugan R. Advances in Engineered Polymer Nanoparticle Tracking Platforms towards Cancer Immunotherapy-Current Status and Future Perspectives. Vaccines (Basel) 2021;9:935. [PMID: 34452059 DOI: 10.3390/vaccines9080935] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gao Y, Zhao Q, Dong H, Xiao M, Huang X, Wu X. Developing Acid-Responsive Glyco-Nanoplatform Based Vaccines for Enhanced Cytotoxic T-lymphocyte Responses Against Cancer and SARS-CoV-2. Adv Funct Mater 2021;31:2105059. [PMID: 34512228 DOI: 10.1002/adfm.202105059] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Li C, Chen C, Wei Y, Tan M, Zhai S, Zhao J, Wang L, Dai T. Cyclodextrin metal-organic framework as vaccine adjuvants enhances immune responses. Drug Deliv 2021;28:2594-602. [PMID: 34866536 DOI: 10.1080/10717544.2021.2012306] [Reference Citation Analysis]
8 Aldosari BN, Alfagih IM, Almurshedi AS. Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines. Pharmaceutics 2021;13:206. [PMID: 33540942 DOI: 10.3390/pharmaceutics13020206] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
9 Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 2021;20:101-24. [PMID: 33277608 DOI: 10.1038/s41573-020-0090-8] [Cited by in Crossref: 182] [Cited by in F6Publishing: 173] [Article Influence: 91.0] [Reference Citation Analysis]
10 Chuang ST, Conklin B, Stein JB, Pan G, Lee KB. Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications. Nano Converg 2022;9:19. [PMID: 35482149 DOI: 10.1186/s40580-022-00310-0] [Reference Citation Analysis]
11 Papież MA, Krzyściak W. Biological Therapies in the Treatment of Cancer-Update and New Directions. Int J Mol Sci 2021;22:11694. [PMID: 34769123 DOI: 10.3390/ijms222111694] [Reference Citation Analysis]
12 Lang S, Tan Z, Wu X, Huang X. Synthesis of Carboxy-Dimethylmaleic Amide Linked Polymer Conjugate Based Ultra-pH-sensitive Nanoparticles for Enhanced Antitumor Immunotherapy. ACS Macro Lett 2020;9:1693-9. [PMID: 33224624 DOI: 10.1021/acsmacrolett.0c00755] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Liu Z, Xu N, Zhao L, Yu J, Zhang P. Bifunctional lipids in tumor vaccines: An outstanding delivery carrier and promising immune stimulator. Int J Pharm 2021;608:121078. [PMID: 34500059 DOI: 10.1016/j.ijpharm.2021.121078] [Reference Citation Analysis]
14 Chung S, Revia RA, Zhang M. Iron oxide nanoparticles for immune cell labeling and cancer immunotherapy. Nanoscale Horiz 2021;6:696-717. [PMID: 34286791 DOI: 10.1039/d1nh00179e] [Reference Citation Analysis]
15 Ahmad MZ, Ahmad J, Haque A, Alasmary MY, Abdel-wahab BA, Akhter S. Emerging advances in synthetic cancer nano-vaccines: opportunities and challenges. Expert Review of Vaccines 2020;19:1053-71. [DOI: 10.1080/14760584.2020.1858058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Briolay T, Petithomme T, Fouet M, Nguyen-Pham N, Blanquart C, Boisgerault N. Delivery of cancer therapies by synthetic and bio-inspired nanovectors. Mol Cancer 2021;20:55. [PMID: 33761944 DOI: 10.1186/s12943-021-01346-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]